Fundraising Fox

Toetal Solutions

Malvern, US · Founded 2020 · Delaware corporation

Toetal Solutions is a medical device company operating in the foot and ankle (podiatric/orthopedic) space, backed by the Runway Healthcare portfolio. The team combines medical device operators and podiatric surgeons focused on lower extremity treatment.

HealthtechMedical Devices

Founders & leadership

JF
Jeffrey F. O'Donnell, Jr.Executive
SP
Stephen P. BancoExecutive
WO
William OdenthalExecutive
JF
Jeffrey F. O'Donnell, Sr.Executive
JO
Jeff O'Donnell, Jr.CEO

Board

WS
William Scott RhodaBoard director

Reported raises · per SEC filings

Form D private placements

$4.8M disclosed across 8 rounds · 2021–2026

▶$100KraisedApr 2026 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey F. O'Donnell, Jr.Executive Officer, Director
  • Nicholas PachudaDirector
  • William Scott RhodaExecutive Officer, Director
  • Jeffrey F. O'Donnell, Sr.Executive Officer, Director
  • William John OdenthalExecutive Officer, Director
Offering amount
$100K
Amount sold
$100K
First sale
Apr 2026
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$950.7KraisedDec 2024 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William John OdenthalExecutive Officer, Director
  • William Scott RhodaExecutive Officer, Director
  • Jeffrey F. O'Donnell, Jr.Executive Officer, Director
  • Jeffrey F. O'Donnell, Sr.Executive Officer, Director
  • Nicholas PachudaDirector
Offering amount
$1M
Amount sold
$950.7K
Sales commissions
$39K
Proceeds to insiders
$225K
Placement agents
"Alere Financial Partners, A division of Cova Capital Partners LLC (""Alere""))"
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100KraisedSep 2024 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey F. O'Donnell, JrExecutive Officer, Director
  • William Scott RhodaDirector
  • Stephen P. BancoExecutive Officer, Director
  • William OdenthalExecutive Officer, Director
  • Jeffrey F. O'Donnell, Sr.Executive Officer, Director
Offering amount
$100K
Amount sold
$100K
Proceeds to insiders
$35K
First sale
Sep 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$430KraisedMay 2024 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nicholas PachudaDirector
  • Jeffrey F. O'Donnell, Sr.Executive Officer, Director
  • William Scott RhodaExecutive Officer, Director
  • William John OdenthalExecutive Officer, Director
  • Jeffrey F. O'Donnell, Jr.Executive Officer, Director
Offering amount
$600K
Amount sold
$430K
Sales commissions
$19.8K
Proceeds to insiders
$100K
Placement agents
Cova Capital Partners LLC
First sale
Mar 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedDec 2023 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nicholas PachudaDirector
  • William Scott RhodaExecutive Officer, Director
  • William John OdenthalExecutive Officer, Director
  • Jeffrey F. O'Donnell, Sr.Executive Officer, Director
  • Jeffrey F. O'Donnell, Jr.Executive Officer, Director
Offering amount
$150K
Amount sold
$150K
Proceeds to insiders
$30K
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedOct 2022 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William Scott RhodaExecutive Officer, Director
  • William OdenthalExecutive Officer, Director
  • Jeffrey F. O'Donnell, Jr.Executive Officer, Director
  • Jeffrey F. O'Donnell, Sr.Executive Officer, Director
  • Nicholas PachudaDirector
Offering amount
$1.8M
Amount sold
$1.8M
Sales commissions
$76.5K
Proceeds to insiders
$350K
Placement agents
Cova Capital Partners LLC
First sale
Oct 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$800KraisedMar 2022 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey F. O'Donnell, Sr.Executive Officer, Director
  • William John OdenthalExecutive Officer, Director
  • Nicholas PachudaDirector
  • William Scott RhodaExecutive Officer, Director
  • Jeffrey F. O'Donnell, Jr.Executive Officer, Director
Offering amount
$800K
Amount sold
$800K
First sale
Mar 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$440KraisedOct 2021 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey F. O'Donnell, Jr.Executive Officer, Director
  • Jeffrey F. O'Donnell, Sr.Executive Officer, Director
  • William John OdenthalExecutive Officer, Director
  • William Scott RhodaExecutive Officer, Director
Offering amount
$440K
Amount sold
$440K
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Toetal Solutions do?
Toetal Solutions is a medical device company operating in the foot and ankle (podiatric/orthopedic) space, backed by the Runway Healthcare portfolio. The team combines medical device operators and podiatric surgeons focused on lower extremity treatment.
How much funding has Toetal Solutions raised?
Toetal Solutions has disclosed $4.8M raised across 8 rounds.
Where is Toetal Solutions headquartered?
Toetal Solutions is headquartered in Malvern, US.